Accuracy of Conflict-of-Interest Disclosures Reported by Physicians

被引:144
作者
Okike, Kanu [1 ,2 ]
Kocher, Mininder S. [3 ,4 ]
Wei, Erin X. [4 ]
Mehlman, Charles T. [5 ]
Bhandari, Mohit [6 ]
机构
[1] Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA 02114 USA
[2] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Univ Cincinnati, Med Ctr, Coll Med,Cincinnati Childrens Hosp, Div Pediat Orthoped Surg, Cincinnati, OH 45267 USA
[6] McMaster Univ, Hamilton Gen Hosp, Dept Orthopaed Surg, Hamilton, ON, Canada
关键词
CLINICAL-TRIALS; PHARMACEUTICAL-INDUSTRY; FUNDING SOURCE; ASSOCIATION; SPONSORSHIP; CONCLUSIONS; OUTCOMES; IMPACT; BIAS;
D O I
10.1056/NEJMsa0807160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The recent public reporting of payments made to physicians by manufacturers of orthopedic devices provides an opportunity to assess the accuracy of physicians' conflict-of-interest disclosures. Methods We analyzed the reports of payments made to physicians by five manufacturers of total hip and knee prostheses in 2007. For each payment recipient who was an author of a presentation or served as a committee member or board member at the 2008 annual meeting of the American Academy of Orthopaedic Surgeons, the disclosure statement was reviewed to determine whether the payment had been disclosed. To ascertain the reasons for nondisclosure, a survey was administered to physicians who had received payments that were not disclosed. Results The overall rate of disclosure was 71.2% (245 of 344 payments). For payments that were directly related to the topic of the presentation at the meeting, the rate was 79.3% (165 of 208); for payments that were indirectly related, the rate was 50.0% (16 of 32); and for payments that were unrelated, the rate was 49.2% (29 of 59) (P = 0.008). In the multivariate analysis, payments were also more likely to have been disclosed if they exceeded $10,000 (P<0.001), were directed toward an individual physician rather than a company or organization (P=0.04), or included an in-kind component (P=0.002). Among the 36 physicians who responded to the survey regarding reasons for nondisclosure (response rate, 39.6%), the reasons most commonly given for nondisclosure were that the payment was unrelated to the topic of presentation at the annual meeting (38.9% of respondents) and that the physician had misunderstood the disclosure requirements (13.9%); 11.1% reported that the payment had been disclosed but was mistakenly omitted from the program. Conclusions In this study of self-reported conflict-of-interest disclosure by physicians at a large annual meeting, the rate of disclosure was 79.3% for directly related payments and 50.0% for indirectly related payments.
引用
收藏
页码:1466 / 1474
页数:9
相关论文
共 40 条
[1]   Association of funding and conclusions in randomized drug trials - A reflection of treatment effect or adverse events? [J].
Als-Nielsen, B ;
Chen, WD ;
Gluud, C ;
Kjaergard, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :921-928
[2]  
*AM AC ORTH SURG, 2008, 2008 ANN M FIN PROGR
[3]   Quantitative analysis of sponsorship bias in economic studies of antidepressants [J].
Baker, CB ;
Johnsrud, MT ;
Crismon, ML ;
Rosenheck, R ;
Woods, SW .
BRITISH JOURNAL OF PSYCHIATRY, 2003, 183 :498-506
[4]   Scope and impact of financial conflicts of interest in biomedical research - A systematic review [J].
Bekelman, JE ;
Li, Y ;
Gross, CP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04) :454-465
[5]   Bias in published cost effectiveness studies: systematic review [J].
Bell, CM ;
Urbach, DR ;
Ray, JG ;
Bayoumi, A ;
Rosen, AB ;
Greenberg, D ;
Neumann, PJ .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7543) :699-701
[6]  
Berenson Alex, 2005, N Y Times Web, pC13
[7]   Factors associated with findings of published trials of drug-drug comparisons: Why some statins appear more efficacious than others [J].
Bero, Lisa ;
Oostvogel, Fieke ;
Bacchetti, Peter ;
Lee, Kirby .
PLOS MEDICINE, 2007, 4 (06) :1001-1010
[8]  
Bhandari M, 2004, CAN MED ASSOC J, V170, P477
[9]  
*BIOM, DEF PROS AGR CO CONS
[10]   Industry-funded positive studies not associated with better design or larger size [J].
Cunningham, Mary R. A. ;
Warme, Winston J. ;
Schaad, Douglas C. ;
Wolf, Fredric M. ;
Leopold, Seth S. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2007, (457) :235-241